...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >EVALUATION OF PROTECTIVE EFFECT OF BASSIA MALABARICA LEAVES AGAINST CISPLATININDUCED NEPHROTOXICITY AND DOXORUBICIN-INDUCED CARDIOTOXICITY IN RATS
【24h】

EVALUATION OF PROTECTIVE EFFECT OF BASSIA MALABARICA LEAVES AGAINST CISPLATININDUCED NEPHROTOXICITY AND DOXORUBICIN-INDUCED CARDIOTOXICITY IN RATS

机译:澳洲青芥叶对CISPLATIN诱导的肾毒性和阿霉素诱导的心血管毒性的防护作用评价

获取原文
           

摘要

Objective: The objective of the current investigation is to study the effect of ethanolic extract of Bassia malabarica leaves (EBML) against cisplatin-induced nephrotoxicity and doxorubicin (DOX)-induced cardiotoxicity in healthy adult male Wistar rats. Methods: Nephrotoxicity was induced by cisplatin (7 mg/kg, i.p ) and cardiotoxicity was induced by DOX (15 mg/kg, i.p ). In both the models, EBML (150 mg/kg and 300 mg/kg, p.o ) was administered for 15 days to assess the prophylactic and curative effect. Urinary parameters, biochemical parameters, and in vivo antioxidants were monitored for nephroprotective effect. For assessing cardioprotective effect serum parameters, cardiac ATPases and in vivo antioxidants were measured. A statistical significance was set at p<0.05 which was analyzed by one-way analysis of variance followed by Tukey’s multiple comparison test. Results: The study results show that the EBML has significantly (p<0.05) restored the urinary parameters, serum parameters of cisplatin-induced nephrotoxic rats, and serum parameters of DOX -induced cardiotoxic rats. A significant decrease (p<0.05) in levels of malondialdehyde and increase in reduced glutathione and catalase were seen in both nephrotoxic and cardiotoxic rats. Ca+2 ATPase was significantly decreased and Na+ K+ ATPase was significantly increased (p<0.05) in the treatment groups when compared to DOX disease control group. Conclusion: EBML showed a protective effect against cisplatin-induced nephrotoxicity and DOX -induced cardiotoxicity.
机译:目的:本研究的目的是研究健康的成年雄性Wistar大鼠的巴西棕榈叶乙醇提取物(EBML)对顺铂诱导的肾毒性和阿霉素(DOX)诱导的心脏毒性的作用。方法:顺铂(7 mg / kg,腹膜内)诱发肾毒性,而DOX(15 mg / kg,腹膜内)诱发心脏毒性。在这两种模型中,EBML(150 mg / kg和300 mg / kg,p.o)给药15天以评估其预防和治疗效果。监测尿参数,生化参数和体内抗氧化剂的肾保护作用。为了评估心脏保护作用,测定了血清参数,心脏ATP酶和体内抗氧化剂。统计显着性设置为p <0.05,然后通过单向方差分析和随后的Tukey多重比较检验进行分析。结果:研究结果表明,EBML显着(p <0.05)恢复了尿参数,顺铂诱导的肾毒性大鼠的血清参数以及DOX诱导的心脏毒性大鼠的血清参数。在肾毒性和心脏毒性大鼠中均发现丙二醛水平显着降低(p <0.05),还原型谷胱甘肽和过氧化氢酶升高。与DOX疾病对照组相比,治疗组中的Ca + 2 ATPase显着降低,而Na + K + ATPase显着升高(p <0.05)。结论:EBML对顺铂引起的肾毒性和DOX引起的心脏毒性具有保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号